Main Title |
Proposed development document for new source performance standards for the pharmaceutical manufacturing point source category. |
CORP Author |
Environmental Protection Agency, Washington, DC. Effluent Guidelines Div. |
Publisher |
Effluent Guidelines Division, Office of Water, U.S. Environmental Protection Agency, |
Year Published |
1983 |
Report Number |
EPA 440/1-83/084-b |
Stock Number |
PB93-206969 |
OCLC Number |
10329168 |
Subjects |
Effluent quality--United States ;
Drug factories--Environmental aspects--United States ;
Water pollution control industry--United States
|
Additional Subjects |
Drug industry ;
Industrial waste treatment ;
Chemical effluents ;
Pollutions regulations ;
Water pollution control ;
Water pollution abatement ;
Waste water ;
Point sources ;
Industrial plants ;
Water pollution sampling ;
Water pollution economics ;
Economic impact ;
Pretreatment ;
Treatment technology ;
BAT(Best Available Technology)
|
Internet Access |
|
Holdings |
Library |
Call Number |
Additional Info |
Location |
Last Modified |
Checkout Status |
EJBD |
EPA 440-1-83-084b |
|
Headquarters Library/Washington,DC |
03/27/2017 |
ELBD ARCHIVE |
EPA 440-1-83-084b |
Received from HQ |
AWBERC Library/Cincinnati,OH |
10/04/2023 |
ERAD |
EPA 440/1-83-084b |
|
Region 9 Library/San Francisco,CA |
10/22/2012 |
ESAD |
EPA 440-1-83-084B |
|
Region 10 Library/Seattle,WA |
03/23/2010 |
NTIS |
PB93-206969 |
Some EPA libraries have a fiche copy filed under the call number shown. |
|
07/26/2022 |
|
Collation |
vii, 61 pages ; 28 cm |
Abstract |
Pharmaceutical plants manufacture biological products, medicinal chemicals, botanical products, and other pharmaceutical products. EPA identified 466 operating facilities involved in the manufacture of pharmaceutical products. Most of the pharmaceutical industry is located in the eastern half of the United States. The most prevalent manufacturing operation in the industry is the formulating, mixing, and compounding operation; batch-type production is the most common type of manufacturing technique for this industry. The wastewaters produced and discharged by the pharmaceutical industry are very diverse. Plant size, products, processes, and materials to which wastewater is exposed vary greatly. Additionally, the ratio of finished product to the quantity of raw materials, solvents, and other processing materials is generally very low. |
Notes |
Cover title: Development document for effluent limitations guidelines and standards for the pharmaceuticals manufacturing. Distributed to depository libraries in microfiche. "September 1983." Includes bibliographical references. "EPA 440/1-83/084-b"--Cover. |
Place Published |
Washington, D.C. |
Supplementary Notes |
See also PB87-172268. |
Corporate Au Added Ent |
United States. Environmental Protection Agency. Effluent Guidelines Division. |
PUB Date Free Form |
1983 |
Ti Tra Differently |
Development document for effluent limitations guidelines and standards for the pharmaceuticals manufacturing.\ New source performance standards for the pharmaceutical manufacturing point source category. |
BIB Level |
m |
Cataloging Source |
OCLC/T |
OCLC Time Stamp |
20121015120128 |
Language |
eng |
SUDOCS Number |
EP 1.2:P 49/2/proposed |
Origin |
OCLC |
Type |
MERGE |
OCLC Rec Leader |
01594cam 2200349Ia 45020 |